New Jersey Better Educational Savings Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-700	Closed	-$293K	–	95
2024 Q1	$293K	Hold	700	–	–	0.55%	56
2023 Q4	$285K	Hold	700	–	–	0.6%	52
2023 Q3	$243K	Hold	700	–	–	0.6%	55
2023 Q2	$246K	Hold	700	–	–	0.58%	60
2023 Q1	$221K	Hold	700	–	–	0.6%	65
2022 Q4	$202K	Hold	700	–	–	0.6%	72
2022 Q3	$203K	Buy	+700	New	+$201K	0.68%	60
2016 Q4	–	Sell	-3,000	Closed	-$262K	–	192
2016 Q3	$262K	Hold	3,000	–	–	0.17%	170
2016 Q2	$258K	Buy	+3,000	New	+$259K	0.17%	174

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

New Jersey Better Educational Savings Trust's VRTX Position: Q2 2024 in Review

New Jersey Better Educational Savings Trust sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 700 shares — an estimated $293K sold.

New Jersey Better Educational Savings Trust first reported a position in VRTX in Q2 2016 and held it in 9 quarters. The position peaked at $293K in Q1 2024. 1,549 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

New Jersey Better Educational Savings Trust reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
New Jersey Better Educational Savings Trust sold 700 Vertex Pharmaceuticals shares in Q2 2024, an estimated $293K.
New Jersey Better Educational Savings Trust first reported a position in Vertex Pharmaceuticals in Q2 2016 and held it in 9 quarters.
New Jersey Better Educational Savings Trust's Vertex Pharmaceuticals position peaked at $293K in Q1 2024.
1,549 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q2 2024, filed 6 Aug 2024.